Arjun Baghela - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Arjun Baghela

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Rheumatology (Oxford, England)|June 24, 2026

Targeting LRRC15 expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseasesXintao Tu, Thao-Nguyen Bach, Arjun Baghela, et al.

Cells|May 13, 2026

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune IndicationsHandan Xiang, Grace Pham Mortenson, Simon B Lang, et al.

Ebiomedicine|January 14, 2022

Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signaturesArjun Baghela, Olga M Pena, Amy H Lee, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Rheumatology (Oxford, England)|June 24, 2026

Targeting LRRC15 expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseasesXintao Tu, Thao-Nguyen Bach, Arjun Baghela, et al.

Cells|May 13, 2026

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune IndicationsHandan Xiang, Grace Pham Mortenson, Simon B Lang, et al.

Ebiomedicine|January 14, 2022

Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signaturesArjun Baghela, Olga M Pena, Amy H Lee, et al.

Pageof 2